Article Archive
Early-stage vacc eradicates HER2 breast cancer in mice
22 September 2008
UK release for Basilea's Toctino
22 September 2008
Positive data for Novartis' pediatric arthritis treatment
22 September 2008
Teva extends collaboration with Proteologics
22 September 2008
JNCI highlights Epeius' cancer drug Rexin-G
22 September 2008
Mylan's generic Risperdal cleared by FDA
22 September 2008
Charles River buys MIR for $22.5M
22 September 2008
Pfizer launches medicine safety web site
22 September 2008
Bayer tops most-visited European pharma web sites
22 September 2008
Action on Australia's PC report urged by MA
22 September 2008
Kenya fights malaria, HIV, diarrheal disease
22 September 2008
Archimedes buys Fennopharma IP
22 September 2008
Pharmacopeia gets GSK milestone
22 September 2008
Bayer Healthcare acquires Direvo Biotech in 210 million-euro cash deal
22 September 2008
Wyeth's Viviant fails to match Lilly's Evista
22 September 2008
Vit B may protect brain in old age
22 September 2008
China Biopharma effects one for 100 stock split
22 September 2008
World Alzheimer's Day: supporting carers
22 September 2008
CVS Caremark extends tender for Longs
22 September 2008
South Africa starts Prevenar program
22 September 2008
Genta will complete AGENDA enrollment
22 September 2008
Micromet reports on breast cancer trial
22 September 2008
Emergent gets HHS nod for Anthrax vacc contract
22 September 2008
New data published on DOR's orBec
22 September 2008
Stallergenes opens allergen facility
22 September 2008
EpiCept amends deal with Durect
22 September 2008
Polyplus develops new class of modified oligonucleotides
22 September 2008
New Prepandrix data from GSK
22 September 2008
FDA approves Talecris' orphan drug for CIDP
22 September 2008
Novartis' FDA priority review for Coartem
22 September 2008
Cognis starts making vitamin E TPGS aimed at pharmaceutical sector
22 September 2008
Two new indications for Merck & Co's HPV vacc
22 September 2008
Biovitrum pays Amgen initial $130M for drugs
22 September 2008
EPO revokes Genentech/Biogen patent
22 September 2008
Akorn signs ophthalmic contract manufacturing deal
22 September 2008
Zosano sees good results for PTH Patch
22 September 2008
Schering-Plough closes sale of animal health products to Pfizer
22 September 2008
Pay Pharma by its results, says UK Conservative shadow Health Sec
22 September 2008
Takeda reigns supreme among Japanese pharma companies
22 September 2008
Malaria ACT drug price negotiations
22 September 2008
South Africa
22 September 2008
AGI's loss deepens on flat revenue
22 September 2008
Oxford Biomedica's loss narrows but CEO quits
22 September 2008
Penn updates on full-year revenue
22 September 2008
Botox sBLA to be filed for chronic migraine
22 September 2008
Novacea discontinues Asentar after hold lifted
22 September 2008
No big change in 2008 results for Genemedix
22 September 2008
King's new offer for Alpharma on hold
22 September 2008
Meda completes buy of Valeant business
22 September 2008
Genentech/Biogen Idec's Rituxan linked to death of RA patient due to PML
22 September 2008
Investors lay new path for Sanofi-Aventis
22 September 2008
bioMerieux buys AviaraDx in $60M deal
22 September 2008
Lilly launches diabetes education program
15 September 2008
Pfizer withdraws European marketing application for Exulett
15 September 2008
Bayer Schering licenses novel PET tracers
15 September 2008
Abraxis signs deal for 4 products with ProMetic
15 September 2008
China hep C market to grow to $150M in 2012
15 September 2008
CMS to blame for Part D marketing lapses?
15 September 2008
Positive top-line Ph II data for Targanta's oritavancin
15 September 2008
NeurAxon's NXN-188 shows pain relief in migraine with aura
15 September 2008
GSK's bird flu vacc on fast-track in Japan
15 September 2008
Eisai set to start testing melanoma drug in fiscal 2009
15 September 2008
AMRI gets $1.5M milestone under B-MS accord
15 September 2008
Novartis' MenB protects infants under six months
15 September 2008
IN CELL ART enters nanocarrier/vacc accord with Sanofi Pasteur
15 September 2008
Erbitux increases overall survival in SCCHN
15 September 2008
EMEA appoints Peter Arlett as head of pharmacovigilance
15 September 2008
Bangladesh's Beximico first to export to Chile
15 September 2008
Ferring appoints Paul Korner VP medical affairs
15 September 2008
Merck & Co's Vioxx lawsuit reinstated, firm may appeal decision
15 September 2008
Bayer shares up on rumored Pfizer takeover
15 September 2008
Invitrogen recruits Joe Beery as head of IT
15 September 2008
Takeda US appoints Gregory Landes as VP of antibody research
15 September 2008
Chemaphor names Paul Dick as CEO
15 September 2008
Halsa consultancy recruits Franz-Josef Kappenberg
15 September 2008
Canada's CIHR reappoints Arnold Steinberg
15 September 2008
Threshold completes $17M financing round
15 September 2008
Biofocus and OneWorld Health extend collaboration
15 September 2008
GSK appoints Ellen Strahlman as CMO
15 September 2008
Oxford Biomedica reports early PD gene therapy results
15 September 2008
Vanda updates on FDA talks regarding iloperidone
15 September 2008
B-MS will not raise bid for ImClone
15 September 2008
Xoma gets $65M NIAID contract
15 September 2008
Novartis' RAD001 gets US priority review
15 September 2008
Xoma's manufacturing agreement with US univ
15 September 2008
Stock Commentary - Europe - week to Sept 8, 2008
15 September 2008
Stock Commentary - New York week to Sept 8, 2008
15 September 2008
Drug equivalent to gastric bypass in 5 years, says UK's UCL
15 September 2008
Hybrigenics receives 1.4M-euro award from OSEO
15 September 2008
ESBAtech completes Ph I study on ophthalmic candidate
15 September 2008
Addex' improved GERD drug greater "commerical potential"
15 September 2008
Merck Serono's Glucophage sachet gets nod from CHMP
15 September 2008
- Elan makes "transformational" acquisitions and a divestment
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- SciClone gains China rights to Zensun's Neucardin
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
